Episode
Weight Loss Drugs Linked to Rare Brain Condition | Colorado Springs News
- Published
- Sep 12, 2026
- Duration seconds
- 103
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/d0c0a81cf6340c8a
Actions
POST https://stenobird.com/v1/public/podcasts/colorado-springs-news-today-2-min-news-the-daily-news-now-7559285/episodes/weight-loss-drugs-linked-to-rare-brain-condition-colorado-springs-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/colorado-springs-news-today-2-min-news-the-daily-news-now-7559285/weight-loss-drugs-linked-to-rare-brain-condition-colorado-springs-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
New science reveals a rare but serious brain condition, Wernicke encephalopathy, linked to popular weight-loss drugs like Ozempic and Wegovy. Fifteen cases in 2023-24 showed patients on GLP-1 meds—containing semaglutide or tirzepatide—developed symptoms from severe vitamin B1 (thiamine) deficiency, including confusion, balance issues, and eye movement problems. Experts suspect the drugs’ appetite-suppressing effects may reduce intake of B1-rich foods like pork, fish, and whole grains. Many patients also suffered from vomiting, poor appetite, or rapid weight loss, signaling deeper nutritional disruption. While these drugs deliver major results for many, this underscores the need for vigilance and balanced nutrition to avoid potentially life-threatening side effects. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/d0c0a81cf6340c8a